These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 38228667)

  • 41. Comparison Between Child-Turcotte-Pugh and Albumin-Bilirubin Scores in Assessing the Prognosis of Hepatocellular Carcinoma After Stereotactic Ablative Radiation Therapy.
    Lo CH; Liu MY; Lee MS; Yang JF; Jen YM; Lin CS; Chao HL; Shen PC; Huang WY
    Int J Radiat Oncol Biol Phys; 2017 Sep; 99(1):145-152. PubMed ID: 28816140
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Application of the albumin-bilirubin grade for predicting prognosis after curative resection of patients with early-stage hepatocellular carcinoma.
    Ma XL; Zhou JY; Gao XH; Tian L; Wu J; Zhang CY; Zhou Y; Dai Q; Wang BL; Pan BS; Yang XR; Guo W
    Clin Chim Acta; 2016 Nov; 462():15-22. PubMed ID: 27520748
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Post-operative albumin-bilirubin grade predicts long-term outcomes among Child-Pugh grade A patients with hepatocellular carcinoma after curative resection.
    Amisaki M; Uchinaka E; Morimoto M; Tokuyasu N; Sakamoto T; Honjo S; Saito H; Fujiwara Y
    Hepatobiliary Pancreat Dis Int; 2018 Dec; 17(6):502-509. PubMed ID: 30077606
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluating liver function and the impact of immune checkpoint inhibitors in the prognosis of hepatocellular carcinoma patients: A systemic review and meta-analysis.
    Tian BW; Yan LJ; Ding ZN; Liu H; Han CL; Meng GX; Xue JS; Dong ZR; Yan YC; Hong JG; Chen ZQ; Wang DX; Li T
    Int Immunopharmacol; 2023 Jan; 114():109519. PubMed ID: 36459922
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic Impact of Albumin-bilirubin (ALBI) Grade on Non-small Lung Cell Carcinoma: A Propensity-score Matched Analysis.
    Kinoshita F; Yamashita T; Oku Y; Kosai K; Ono Y; Wakasu S; Haratake N; Toyokawa G; Takenaka T; Tagawa T; Shimokawa M; Nakashima N; Mori M
    Anticancer Res; 2021 Mar; 41(3):1621-1628. PubMed ID: 33788758
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Preoperative albumin-bilirubin grade plus platelet-to-lymphocyte ratio predict the outcomes of patients with BCLC stage A hepatocellular carcinoma after liver resection.
    Li C; Zhang XY; Peng W; Wen TF; Yan LN; Li B; Yang JY; Wang WT; Xu MQ; Chen LP
    Medicine (Baltimore); 2018 Jul; 97(29):e11599. PubMed ID: 30024565
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Usefulness of albumin-bilirubin grade for evaluation of prognosis of 2584 Japanese patients with hepatocellular carcinoma.
    Hiraoka A; Kumada T; Michitaka K; Toyoda H; Tada T; Ueki H; Kaneto M; Aibiki T; Okudaira T; Kawakami T; Kawamura T; Yamago H; Suga Y; Miyamoto Y; Tomida H; Azemoto N; Mori K; Miyata H; Ninomiya T; Kawasaki H
    J Gastroenterol Hepatol; 2016 May; 31(5):1031-6. PubMed ID: 26647219
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical Utility of Albumin Bilirubin Grade as a Prognostic Marker in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: a Systematic Review and Meta-analysis.
    Mishra G; Majeed A; Dev A; Eslick GD; Pinato DJ; Izumoto H; Hiraoka A; Huo TI; Liu PH; Johnson PJ; Roberts SK
    J Gastrointest Cancer; 2023 Jun; 54(2):420-432. PubMed ID: 35635637
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The role of albumin-bilirubin grade in determining the outcomes of patients with very early-stage hepatocellular carcinoma.
    Chang CY; Wei CY; Chen PH; Hou MC; Chao Y; Chau GY; Lee RC; Huang YH; Su YH; Wu JC; Su CW
    J Chin Med Assoc; 2021 Feb; 84(2):136-143. PubMed ID: 33433133
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Assessment of the Albumin-Bilirubin (ALBI) Grade as a Prognostic Indicator for Hepatocellular Carcinoma Patients Treated With Radioembolization.
    Gui B; Weiner AA; Nosher J; Lu SE; Foltz GM; Hasan O; Kim SK; Gendel V; Mani NB; Carpizo DR; Saad NE; Kennedy TJ; Zuckerman DA; Olsen JR; Parikh PJ; Jabbour SK
    Am J Clin Oncol; 2018 Sep; 41(9):861-866. PubMed ID: 28418940
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A multicentre comparison between Child Pugh and Albumin-Bilirubin scores in patients treated with sorafenib for Hepatocellular Carcinoma.
    Edeline J; Blanc JF; Johnson P; Campillo-Gimenez B; Ross P; Ma YT; King J; Hubner RA; Sumpter K; Darby S; Evans J; Iwuji C; Swinson D; Collins P; Patel K; Muazzam I; Palmer DH; Meyer T
    Liver Int; 2016 Dec; 36(12):1821-1828. PubMed ID: 27214151
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tumor burden score as a new prognostic surrogate in patients with hepatocellular carcinoma undergoing radiofrequency ablation: role of albumin-bilirubin (ALBI) grade vs easy ALBI grade.
    Ho SY; Liu PH; Hsu CY; Huang YH; Liao JI; Su CW; Hou MC; Huo TI
    Expert Rev Gastroenterol Hepatol; 2022 Sep; 16(9):903-911. PubMed ID: 35999514
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immune inflammation indicators and ALBI score to predict liver cancer in HCV-patients treated with direct-acting antivirals.
    Casadei Gardini A; Foschi FG; Conti F; Petracci E; Vukotic R; Marisi G; Buonfiglioli F; Vitale G; Ravaioli F; Gitto S; Verucchi G; Lenzi M; Bolondi L; Mazzella G; Brillanti S; Andreone P;
    Dig Liver Dis; 2019 May; 51(5):681-688. PubMed ID: 30327251
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Albi Score as a Predictor of Survival in Patients with Compensated Cirrhosis Resected for Hepatocellular Carcinoma: Exploratory Evaluation in Relationship to Palbi and Meld Liver Function Scores.
    Božin T; Mustapić S; Bokun T; Patrlj L; Rakić M; Aralica G; Kujundžić M; Trkulja V; Grgurević I
    Acta Clin Croat; 2018 Jun; 57(2):292-300. PubMed ID: 30431722
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prognostic Role of Albumin, Bilirubin, and ALBI Scores: Analysis of 1000 Patients with Hepatocellular Carcinoma Undergoing Radioembolization.
    Antkowiak M; Gabr A; Das A; Ali R; Kulik L; Ganger D; Moore C; Abecassis M; Katariya N; Mouli S; Mahalingam D; Lewandowski RJ; Salem R; Riaz A
    Cancers (Basel); 2019 Jun; 11(6):. PubMed ID: 31238514
    [No Abstract]   [Full Text] [Related]  

  • 56. Potential of PALBI-T score as a prognostic model for hepatocellular carcinoma in alcoholic liver disease.
    Tanaka K; Tsuji K; Matsui T; Kang JH; Sakurai Y; Kodama Y; Minami R; Watanabe K; Katanuma A
    JGH Open; 2022 Jan; 6(1):36-43. PubMed ID: 35071786
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prognostic value of pretreatment albumin to bilirubin ratio in patients with hepatocellular cancer: A meta-analysis.
    Xu YX; Wang YB; Tan YL; Xi C; Xu XZ
    Medicine (Baltimore); 2019 Jan; 98(2):e14027. PubMed ID: 30633195
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical Significance of Preoperative Albumin-Bilirubin Grade in Pancreatic Cancer.
    Imamura T; Okamura Y; Sugiura T; Ito T; Yamamoto Y; Ashida R; Ohgi K; Otsuka S; Uesaka K
    Ann Surg Oncol; 2021 Oct; 28(11):6223-6235. PubMed ID: 33486645
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A New Prognostic Model Based on Albumin-Bilirubin Grade for Hepatocellular Carcinoma Beyond the Milan Criteria.
    Ho SY; Liu PH; Hsu CY; Hsia CY; Huang YH; Su CW; Lei HJ; Lee RC; Hou MC; Huo TI
    Dig Dis Sci; 2020 Feb; 65(2):658-667. PubMed ID: 31659612
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Baseline Albumin-Bilirubin (ALBI) Score in Western Patients With Hepatocellular Carcinoma Treated With Stereotactic Body Radiation Therapy (SBRT).
    Murray LJ; Sykes J; Brierley J; Kim JJ; Wong RKS; Ringash J; Craig T; Velec M; Lindsay P; Knox JJ; Dawson LA
    Int J Radiat Oncol Biol Phys; 2018 Jul; 101(4):900-909. PubMed ID: 29976502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.